Fentanyl, 250 mcg/ 5mL, Injection for IV or IM use, Rx only, SCA Pharmaceuticals, 8821 Knoedl Ct....
FDA Drug Recall #D-0147-2021 — Class III — November 20, 2020
Recall Summary
| Recall Number | D-0147-2021 |
| Classification | Class III — Low risk |
| Date Initiated | November 20, 2020 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | SCA Pharmaceuticals |
| Location | Windsor, CT |
| Product Type | Drugs |
| Quantity | 4,843 syringes |
Product Description
Fentanyl, 250 mcg/ 5mL, Injection for IV or IM use, Rx only, SCA Pharmaceuticals, 8821 Knoedl Ct., Little Rock, AR 72205
Reason for Recall
Subpotency: Out-of-specification stability test result for low potency was obtained.
Distribution Pattern
Product was distributed to three hospitals in MO & LA.
Lot / Code Information
Lot #: 1220021578, Exp 12/2/2020; 1220021732, Exp 12/9/2020; 1220022385, Exp 12/29/2020; 1220022582, Exp 1/6/2021
Other Recalls from SCA Pharmaceuticals
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0945-2023 | Class II | FentaNYL 500 mcg/250 mL - Bupivacaine HCl 0.1% ... | Jul 20, 2023 |
| D-0555-2023 | Class III | Oxytocin 30 units added to 0.9% Sodium Chloride... | Apr 10, 2023 |
| D-0363-2023 | Class III | Fentanyl 1,500 mcg/30 mL syringe, Injection for... | Feb 24, 2023 |
| D-0829-2022 | Class II | Norepinephrine 8mg in 0.9% Sodium Chloride 250 ... | Apr 25, 2022 |
| D-0831-2022 | Class II | Vancomycin HCl 1.5 g in 0.9% Sodium Chloride, 5... | Apr 25, 2022 |
Frequently Asked Questions
Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.